IMCR Institutional Ownership
Immunocore Holdings plc
Latest close $33.29 as of Aug 5, 2026
IMCR institutional ownership at a glance
Follow Immunocore Holdings plc institutional ownership through recent Schedule 13G and 13D filings. Compare reported shares, ownership percentages, filing dates, and changes in beneficial ownership over time.
Latest filing: T. Rowe Price Investment Management filed Schedule 13G amendment on May 15, 2026, reporting 1.9M shares and 12.00% beneficial ownership.
How to read Schedule 13 ownership changes
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices.
Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
For more context, see how to read a Schedule 13G, filing date vs event date, or Schedule 13G vs Schedule 13D.
Institutional Research
This gauge summarizes recent agreement across tracked institutional activity.
1 reducing across 1 comparable institution.
The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.
Price context
52-week position is market context and does not change the institutional consensus score.
Tracked institutions
Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.
Beneficial ownership filing history
Showing 3 of 7 filing(s) · 4 older require more history access| Holder | Observed / filed | Reported change | Shares | Ownership | Observation | Filing | Latest |
|---|---|---|---|---|---|---|---|
| T. Rowe Price Investment Management CIK0001897612 | Mar 31, 2026 observed May 15, 2026 filed · 45d Schedule 13G amendment | Reported reduction | 1.9M -1.2M | 12.00% 0.00 pts | $30.15 | $28.05 | $33.29 |
| T. Rowe Price Investment Management CIK0001897612 | Feb 28, 2026 observed Mar 6, 2026 filed · 6d Schedule 13G amendment | Reported reduction | 3.0M -2.9M | 12.00% 0.00 pts | $32.30 | $32.94 | $33.29 |
| T. Rowe Price Investment Management CIK0001897612 | Dec 31, 2025 observed Feb 17, 2026 filed · 48d Schedule 13G amendment | Reported reduction | 6.0M -1.1M | 12.00% -2.10 pts | $34.71 | $32.38 | $33.29 |
Related research
Compare IMCR with other securities showing similar institutional activity or recent accumulation across several tracked institutions.